Home Industries Market Insights About Us Publisher Contact us

Osteoarthritis Market Size, Share & Trends Analysis Report By Anatomy (knee osteoarthritis, hand osteoarthritis, hip osteoarthritis, and small joint osteoarthritis), by Drug Type (Naproxen, Aspirin, Diclofenac, Ibuprofen, and Others), by Route of Administration (Parenteral Route, Topical Route, And Oral Route), By Purchasing Pattern (Prescription Drugs, And Over-The-Counter Drugs), by Distribution Channel (Spital Pharmacy, Retail And Online Pharmacies), Region (North America, Europe, Asia-Pacific, Middle East & Africa, and South America)—Forecast till 2028

Categories: Life Science

Formate :

"The Global Osteoarthritis Market is estimated at USD 7.12 billion in 2020, and it is expected to reach 12.45 billion USD by the year 2028 with a CAGR of 8.7%."


Report Overview

The report titled “Global Osteoarthritis Market - Growth, Share, Opportunities, and Competitive Analysis, 2021 – 2028” offers strategic visions into the global Osteoarthritis market along with the market size (Revenue – US$ Billion) and estimates for the duration 2016 to 2028. The said research study covers in-depth analysis of multiple market segments based on anatomy, drug type, route of administration, purchasing pattern, distribution channel, and study across different topographies. The report is also inclusive of competitive profiling of the leading osteoarthritis market vendors, and the latest developments.


Market Synopsis

Osteoarthritis is the most common musculoskeletal condition that is characterized by thinning of cartilage in joints, resulting in bones grinding together, causing stiffness, discomfort, and limited movement. Osteoarthritis is also known as degenerative joint disease, or wear and tear arthritis. Osteoarthritis is the leading cause of disability among the elderly worldwide. In this type of disease, the cartilage in a joint begins to deteriorate, and underlying bone starts changing. These alterations normally take time to manifest however, get worse over time period. The major symptoms and sign includes swelling, pain or aching, stiffness and decreased range of motion (or flexibility). Owing to high cases of Osteoarthritis, many key pharmaceutical companies are active in the osteoarthritis therapeutics market. 


Market Dynamics

The increasing geriatric population is the major cause behind the global osteoarthritis market growth as the disease is prominently found in the elderly population. As per the data release by United Nations in 2017, the global population aged 60 or above was 962 million in 2017, and by 2050, it is expected to reach approximately 2.1 billion. As per the data given by Lancet Journal, Osteoarthritis affects about 7% of the global population, which is more than 500 million people worldwide. However, the use of nonsteroidal anti-inflammatory drugs in the treatment of osteoarthritis increases the chances of adverse cardiovascular incidents thereby, hampering the market growth. Additionally, the adoption of biomarkers in the treatment along with the utilization of AI technology might increase the trend of personalized medicine ultimately generating lucrative opportunities for the global osteoarthritis market players.


Market Segmentation

The global osteoarthritis market has been segmented based on anatomy, drug type, route of administration, purchasing pattern, and distribution channel, and geography.  Based on anatomy, the global osteoarthritis market has been segmented into knee osteoarthritis, hand osteoarthritis, hip osteoarthritis, and small joint osteoarthritis.  The worldwide osteoarthritis market is divided into viscosupplementation agents, nonsteroidal anti-inflammatory medicines (NSAIDs), corticosteroids, and analgesics based on medication type. Nonsteroidal Anti-inflammatory Drugs (NSAIDs) can be further segmented into naproxen, aspirin, diclofenac, ibuprofen, and others. Moreover, Analgesics can be differentiated into, duloxetine, and acetaminophen. Based on route of administration, the global osteoarthritis market has been segmented into parenteral route, topical route, and oral route. On the basis of purchasing pattern, the osteoarthritis market has been segmented into prescription drugs, and over-the-counter drugs. On the basis of distribution channel, the osteoarthritis market has been segmented into hospital pharmacy, retail and online pharmacies. Among various anatomy categories, knee osteoarthritis is expected to dominate the market. Viscosupplementation agents held the largest part of the drug type segment and it is anticipated that this category will again dominate the market over the forecast period.


Geographical Overview

Based on geography, the global osteoarthritis market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America comprises U.S., Canada, and Mexico whereas Europe would primarily cover Germany, France, UK, Italy, and Rest of Europe. The key countries mentioned under Asia Pacific are China, Japan, India, Australia, and Rest of Asia Pacific. In Latin America, Brazil, Argentina, and Rest of Latin America are the key regional segments whereas, in Middle East & Africa, South Africa and Rest of MEA are the key regions covered in the report. The North American region is anticipated to dominate the global osteoarthritis market owing to growing geriatric population along with rising obesity in the region. Moreover, extensive research and development activities to develop novel therapies and drugs is another factor that is expected to support the regional growth. Europe is expected to follow the trend after North America.


Competitive Landscape

The global osteoarthritis market is characterized by the presence of leading manufacturers such as Sanofi, Horizon Therapeutics PLC, Johnson & Johnson, GlaxoSmithKline PLC, Bayer AG, Abbott, Pfizer, Inc., Eli Lilly, Anika Therapeutics, Inc., Novartis AG, Ferring Pharmaceuticals, Bioventus, Zimmer Biomet Holdings, Inc., Fidia Farmaceutici s.p.a., Flexion Therapeutics Inc., Pharmed Limited, Virchow Biotech, Kitov Pharmaceuticals Ltd, Assertio Therapeutics, Inc., Atnahs, OrthogenRx, LABRHA, Hanmi Pharm. Co., Ltd., Laboratorio Reig Jofre, Bayer AG, and Mylan among others.





Global Osteoarthritis Market Growth, Trend and Forecast 2021-2028

Chapter 1 Osteoarthritis Market Overview
1.1 Product Overview and Scope of Osteoarthritis
1.2 Osteoarthritis Market Segmentation by Type
1.2.1 Global Production Market Share of Osteoarthritis by Type in 2020
1.2.1 Type 1
1.2.2 Type 2
1.2.3 Type 3
1.3 Osteoarthritis Market Segmentation by Application
1.3.1 Osteoarthritis Consumption Market Share by Application in 2020
1.3.2 Application 1
1.3.3 Application 2
1.3.4 Application 3
1.4 Osteoarthritis Market Segmentation by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
1.5 Global Market Size (Value) of Osteoarthritis (2014-2028)

Chapter 2 Global Economic Impact on Osteoarthritis Industry
2.1 Global Macroeconomic Environment Analysis
2.1.1 Global Macroeconomic Analysis
2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

Chapter 3 Global Osteoarthritis Market Competition by Manufacturers
3.1 Global Osteoarthritis Production and Share by Manufacturers (2020 and 2020)
3.2 Global Osteoarthritis Revenue and Share by Manufacturers (2020 and 2020)
3.3 Global Osteoarthritis Average Price by Manufacturers (2020 and 2020)
3.4 Manufacturers Osteoarthritis Manufacturing Base Distribution, Production Area and Product Type
3.5 Osteoarthritis Market Competitive Situation and Trends
3.5.1 Osteoarthritis Market Concentration Rate
3.5.2 Osteoarthritis Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion

Chapter 4 Global Osteoarthritis Production, Revenue (Value) by Region (2014-2021)
4.1 Global Osteoarthritis Production by Region (2014-2021)
4.2 Global Osteoarthritis Production Market Share by Region (2014-2021)
4.3 Global Osteoarthritis Revenue (Value) and Market Share by Region (2014-2021)
4.4 Global Osteoarthritis Production, Revenue, Price and Gross Margin (2014-2021)
4.5 North America Osteoarthritis Production, Revenue, Price and Gross Margin (2014-2021)
4.6 Europe Osteoarthritis Production, Revenue, Price and Gross Margin (2014-2021)
4.7 China Osteoarthritis Production, Revenue, Price and Gross Margin (2014-2021)
4.8 Japan Osteoarthritis Production, Revenue, Price and Gross Margin (2014-2021)
4.9 Southeast Asia Osteoarthritis Production, Revenue, Price and Gross Margin (2014-2021)
4.10 India Osteoarthritis Production, Revenue, Price and Gross Margin (2014-2021)

Chapter 5 Global Osteoarthritis Supply (Production), Consumption, Export, Import by Regions (2014-2021)
5.1 Global Osteoarthritis Consumption by Regions (2014-2021)
5.2 North America Osteoarthritis Production, Consumption, Export, Import by Regions (2014-2021)
5.3 Europe Osteoarthritis Production, Consumption, Export, Import by Regions (2014-2021)
5.4 China Osteoarthritis Production, Consumption, Export, Import by Regions (2014-2021)
5.5 Japan Osteoarthritis Production, Consumption, Export, Import by Regions (2014-2021)
5.6 Southeast Asia Osteoarthritis Production, Consumption, Export, Import by Regions (2014-2021)
5.7 India Osteoarthritis Production, Consumption, Export, Import by Regions (2014-2021)

Chapter 6 Global Osteoarthritis Production, Revenue (Value), Price Trend by Type
6.1 Global Osteoarthritis Production and Market Share by Type (2014-2021)
6.2 Global Osteoarthritis Revenue and Market Share by Type (2014-2021)
6.3 Global Osteoarthritis Price by Type (2014-2021)
6.4 Global Osteoarthritis Production Growth by Type (2014-2021)

Chapter 7 Global Osteoarthritis Market Analysis by Application
7.1 Global Osteoarthritis Consumption and Market Share by Application (2014-2021)
7.2 Global Osteoarthritis Consumption Growth Rate by Application (2014-2021)
7.3 Market Drivers and Opportunities
7.3.1 Potential Applications
7.3.2 Emerging Markets/Countries

Chapter 8 Osteoarthritis Manufacturing Cost Analysis
8.1 Osteoarthritis Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Osteoarthritis

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Osteoarthritis Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Osteoarthritis Major Manufacturers in 2020
9.4 Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

Chapter 11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

Chapter 12 Global Osteoarthritis Market Forecast (2021-2028)
12.1 Global Osteoarthritis Production, Revenue Forecast (2021-2028)
12.2 Global Osteoarthritis Production, Consumption Forecast by Regions (2021-2028)
12.3 Global Osteoarthritis Production Forecast by Type (2021-2028)
12.4 Global Osteoarthritis Consumption Forecast by Application (2021-2028)
12.5 Osteoarthritis Price Forecast (2021-2028)

Chapter 13 Appendix





















Request For List Of Tables

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any)


How big is the Osteoarthritis market?

The global Osteoarthritis market was valued at 7.12 billion USD in the year 2020.

Choose License Type

Single User

US$ 3500

Multi User

US$ 5250

Corporate User

US$ 7000

Personalize this Research

  • Market Size and Share from 2016 - 2027
  • Expected Market Growth Until 2027
  • COVID-19 Impact assessment on the market
  • Market Dynamics and Impact Analysis
  • Segment and region that will drive or lead the market growth and why
  • Industry activity comprising Mergers, Acquisitions, Expansion, etc.
  • Comprehensive Mapping of the Competitive Landscape
  • In-depth analysis of key sustainability strategies adopted by market players
  • Global and regional market trends – Current and Future
  • Value Chain Analysis
  • Porters Five Forces Analysis
  • Historical and Current Product Pricing
  • Country Cross-Segment Analysis
  • Company Profiling
  • Player Comparison Matrix

Life Science Clients

Osteoarthritis Market Size, Share & Trends Analysi...

RD Code : HP21